Eric Metzen

8.2k citations
51 papers · 6.8k indexed · 1 hit paper · h-index 30

Eric Metzen

51 papers receiving 6.7k citations

Hit Papers

C. elegans EGL-9 and Mammalian Homologs Define a Family o...2.7k200120262009201750010001.5k2.0k2.5k

Peers

Eric Metzen
Comparison fields: 5 of 136
  • Cancer Research 4.5k
  • Biochemistry 531
  • Aging 109
  • Molecular Biology 3.8k
  • Genetics 1.3k
Replace Norma Masson with:
Norma Masson United Kingdom
Panu Jaakkola Finland
Peppi Koivunen Finland
Edurne Berra France
Richard K. Bruick United States
Mircea Ivan United States
Ya‐Min Tian United Kingdom
Matthew E. Cockman United Kingdom
Michael Ohh Canada
Haifeng Yang United States
Eric Metzen relative to Norma Masson United Kingdom Norma Masson's profile →
Citations per field
00.5×
Norma Masson · 1×
Citations per year

Countries citing papers authored by Eric Metzen

Since Specialization
Citations

This map shows the geographic impact of Eric Metzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Metzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Metzen more than expected).

Fields of papers citing papers by Eric Metzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Metzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Metzen. The network helps show where Eric Metzen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eric Metzen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Metzen Line = papers co-authored together Eric Metzen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20233
2 20207
3 201831
4 201811
5 201783
6 201649
7 2012107
8 201116
9 201110
10 201061
11 200852
12 2007115
13 200778
14 200761
15 200642
16 2005217
17 200560
18 200458
19 2004146
20 20012

About Eric Metzen

Eric Metzen is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 51 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (31 papers), Mitochondrial Function and Pathology (14 papers), High Altitude and Hypoxia (11 papers), Adipose Tissue and Metabolism (5 papers), Erythropoietin and Anemia Treatment (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Cancer Research (4.5k citations), Biochemistry (531 citations) and Aging (109 citations). Eric Metzen has collaborated with scholars based in Germany, Finland and China. Frequent co-authors include Wolfgang Jelkmann, Joachim Fandrey, Thomas Hellwig‐Bürgel, Peter J. Ratcliffe, Panu Jaakkola, Michael Wilson, Jonathan Hodgkin, Donald L. Hamilton, Christopher W. Pugh and Ya‐Min Tian. Their work appears in journals such as Blood, Journal of Cell Science, Biochemical Journal, Scientific Reports and Annals of Anatomy - Anatomischer Anzeiger.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026